GX H9Alternative Names: GX-H9; hGH-hyFc; HL 2356; Long-acting human growth hormone - Genexine; Somatropin long-acting - Genexine/Handok
Latest Information Update: 23 Nov 2016
At a glance
- Originator Genexine
- Developer Genexine; Handok Inc
- Class Growth hormones; Hormonal replacements; Recombinant fusion proteins
- Mechanism of Action Somatotropin receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Somatotropin deficiency